Evidence map›Paper›PMID 39789136›Full record

ArticleBone marrow transplantation2025

aGvHDtrackR and cGvHDtrackR: shiny applications for graft versus host disease management and clinical data collection.

Marco Maria Sindoni, Francesca Limido, Anita Toso, Giovanna Lucchini, Giuseppe Gaipa, Adriana Balduzzi, Silvia Nucera

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marco Maria SindoniSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Francesca LimidoSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Anita TosoSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Giovanna LucchiniPediatric Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Giuseppe GaipaTettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Adriana BalduzziSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy. adriana.balduzzi@unimib.it.
Silvia NuceraSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy. silvia.nucera@unimib.it.ORCID 0000-0001-9489-142X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Graft-versus-host disease (GvHD) is one of the most common and troublesome complications after allogeneic hematopoietic stem cell transplantation (HSCT). Despite adequate GvHD prophylaxis, 30-50% of the patients still develop acute or chronic GvHD, often requiring multiple lines of therapy. Therefore, it is crucial to closely monitor the onset and the response of GvHD to therapies to identify the best available treatment for each patient. Currently, some applications (desktop or mobile) that allow to score GvHD severity at the bedside are available. However, none of the published systems is designed to record ongoing therapies and to upload data in a database, which can support both the clinical decision-making process as well as data collection. To this aim, we developed two Shiny apps: aGvHDtrackR for acute GvHD and cGvHDtrackR for chronic GvHD. These applications record GvHD grading alongside the therapies used for each patient and allow to export of the data in a longitudinal patient-specific database. This is of help for the clinical management of patients and for future multicentric studies on GvHD.

Indexed as

Data CollectionGraft vs Host DiseaseHematopoietic Stem Cell TransplantationChronic DiseaseDisease ManagementFemaleHumansMale

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.